Biosecurity is not an abstract concept; it’s the foundation of global trust in science and innovation, said Prof. Aamer Ikram. Through this Consortium, we have a unique opportunity to translate that trust into action by setting shared standards that protect everyone while enabling life sciences to thrive.

Prof. Aamer Ikram is a leading voice in global health security and biosafety governance, bringing decades of experience bridging science, policy, and public health leadership. He serves in multiple strategic advisory roles, including Chair Advisory Board TEPHINET; Vice-President IANPHI; Regional Technical Advisor EMPHNET; member TAG-Biosafety, WHO; Partnership for International Vaccine Initiatives; Governance Committee GAVI; APHEA. Previously, he served on numerous international boards including Chair Board International Federation of Biosafety Associations; member WHO TAG-Health Security Interface.

As Chair and Strategic Advisor within the IBBIS Technical Consortium, Prof. Ikram brings his expertise in building resilient health systems, laboratory networks, and biorisk management frameworks across Asia, Africa, and the Middle East. His long-standing commitment to strengthening biosafety and biosecurity capacity globally ensures that new international DNA synthesis screening standards will reflect both scientific excellence and on-the-ground realities.